Atlas Trials

Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases

Clinical trial NCT02185352 · UNKNOWN

Trial details

NCT number
NCT02185352
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerBrain Metastases
Start date
2014-04-21
Primary completion
2019-11-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.